PathAI

AI-powered pathology platform to improve patient outcomes through precision diagnostics

Enterprise·Technical·Powered by PathAI (proprietary)·API available

Key strengths

AI-powered pathology algorithmsLarge proprietary pathologist contributor network (450+ board-certified pathologists)Extensive annotation dataset (32.5M+ annotations)FDA-cleared digital pathology platform (AISight® Dx)CE-IVDR marked platformBiomarker discovery and drug development supportCloud-native open platform enterprise workflow (AISight®)

Enterprise pricing

Boston, USA

Founded 2016

Facts verified against pathai.com on Oct 5, 2026

Get alerts when PathAI changes

Free. We'll email you when pricing, the free tier, API access or open-source status changes.

No ratings yet

PathAI – Technical Overview

PathAI delivers an AI-powered digital pathology platform designed for integration into enterprise anatomic pathology workflows. Its flagship offerings include:

AISight® – A cloud-native, open-platform enterprise workflow solution built to support anatomic pathology institutions including academic medical centers, reference laboratories, and health systems.
AISight® Dx – An FDA-cleared and CE-IVDR marked digital pathology platform, enabling regulatory-grade deployment of AI pathology algorithms in clinical settings.

The platform is underpinned by a proprietary dataset of 32.5M+ pathologist annotations contributed by a network of 450+ board-certified pathologists, providing the training foundation for its AI algorithms. PathAI supports biomarker discovery and drug development pipelines, making it a fit for BioPharma R&D environments.

Integrations: Deep Bio, Paige, Visiopharm, DoMore Diagnostics

Alternatives